The trillions of bacteria that reside in the human gut are known to play a critical role in promoting mental and physical health. But new research shows that the gut microbiome can also harbor potential bad actors.
Functional screening of human gut microbiota reveals a family of small molecule genotoxins called indolimines in patients with inflammatory bowel disease (IBD), according to a new study.
A team of Yale scientists identified a novel family of “genotoxins” produced by human gut bacteria that can damage DNA and may contribute to colorectal cancer.